In addition, since ProTBGS is also a very useful outcome predictor in patients with ICNSTs independent of intrinsic subtype, patient age, or Ki-67 labeling index, we can conclude that ProTBGS is a very useful outcome predictor in patients with ICNNSTs, independent of the biological characteristics of the tumor/patients. Here, MKI67 is linked to neoplasm.